CLDN2 and neoplasm: Previous studies that examined the expression of claudin-2 and claudin-3 during the transformation from normal tissue to endometrioid adenocarcinoma showed that their expression increases with the progression of the tumor, suggesting that these proteins could serve as good biomarkers for early diagnosis of premalignant lesions [65].